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Gregory L. Moneta, MD, Section EditorFifty Percent Area Reduction After Four Weeks of Treatment is a
Reliable Indicator for Healing—Analysis of a Single-Center Cohort of
704 Diabetic Patients
Coerper S, Beckert S, Kuper MA, et al. J Diabetes Complications 2009;23:
49-53.
Conclusion: Calculating wound area reduction after 4 weeks is a valid
tool to estimate the probability that a diabetic foot wound will heal. A 50%
wound area reduction after 4 weeks of therapy indicates likely healing of a
diabetic foot wound.
Summary: Subjective and wound-based parameters can be used to
document healing of diabetic foot wounds. The only objective wound-based
parameters for healing are wound size and ultimate complete wound closure.
The authors sought to investigate whether an area reduction 50% with 4
weeks of treatment was associated with long-term probability that a diabetic
foot wound would heal.
The authors treated diabetic foot wounds according to an institutional,
interdisciplinary wound care protocol. Follow-up was documented using a
wound care documentation system and data were analyzed. The probability
of healing was assessed with the Kaplan-Meier method, with results ex-
pressed as percentage of area reduction. Patients were classified as responders
to the protocol when the percentage of wound area reduction reached at
least 50% after 4 weeks of treatment, and nonresponders when the percent-
age area reduction was 50% at 4 weeks. Healing was defined as a percent-
age area reduction of 100%.
The analyses included 704 patients with a median follow-up of 71 days
(range, 2-365 days). Wound duration was 31 days (range, 1-4018 days).
Initial wound size was 1.18 cm2 (range, 0.1-99 cm2). Bone was involved in
the base of the wound in 28%, and in 64.5% both pedal pulses were not
palpable. Major amputation rate was 2.8%, and minor amputation rate was
10.2%. Overall probability of healing was 35% after 12 weeks, 41% after 16
weeks, and 73% after 1 year. There were 334 responders (47%) and 370
nonresponders (53%). Responders had a significantly higher probability of
healing compared with nonresponders (12 weeks: 52% vs 18%, P  .0001;
16 weeks: 47% vs 27%, P  .0001; 1 year: 83% vs 65%, P  .0001).
Comment: The data suggest that diabetic foot wounds more prone to
heal will exhibit a greater healing response early in the course of their
treatment. The practical point is that if the wound has not decreased by 50%
in area after 4 weeks, an alternative form of wound therapy should be
considered.
Plasma Levels of Soluble Tie2 and Vascular Endothelial Growth Factor
Distinguish Critical Limb Ischemia from Intermittent Claudication in
Patients with Peripheral Arterial Disease
Findley CM, Mitchell RG, Duscha BD, et al. J Am Coll Cardiol 2008;52:
387-93.
Conclusion: VEGF and sTie2 are increased in critical limb ischemia.
sTie2 may be a marker and a cause of critical limb ischemia.
Summary: Patients with peripheral arterial disease (PAD) are at in-
creased risk for cardiovascular mortality. Risk is higher for those patients
with critical limb ischemia (CLI) vs those with intermittent claudication
(IC). The diagnosis of IC vs CLI is, however, purely clinical. In addition,
although a lower ankle-brachial index (ABI) is also a marker for increased
cardiovascular mortality, ABI does not distinguish between CLI and IC. A
potential biomarker that can distinguish between patients with CLI and IC
may therefore be useful in risk stratification in patients with PAD.
The authors are expert in fields of angiogenesis, and it is known that
alterations in angiogenic growth factors occur in patients with vascular
disease. It is, however, unknown whether these growth factors are altered in
the subset of cardiovascular disease patients with PAD or whether these
potential alterations in growth factors can correlate with the disease severity.
In this study the authors therefore sought to determine whether factors that
regulate angiogenesis are altered in PAD and if these alternations exist,
whether they are associated with PAD severity.
Plasma was collected from 46 patients with PAD (23 with IC and 23
with CLI) and 23 healthy controls. Plasma angiopoietin-2 (Ang2), soluble
Tie2 (sTie2), vascular endothelial growth factor (VEGF), soluble VEGF
receptor 1 (sVEGFR-1), and placenta growth factor (PlGF) were measured
from the plasma samples. In vitro studies of endothelial cells were also per-
formed with recombinant VEGF to investigate effects on sTie2 production.
Concentrations of sTie2 (P .01), Ang2 (P .001), and VEGF (P
.01) were significantly greater in PAD patients compared with controls. No
differences were found in PlGF or sVEGFR-1. Plasma Ang2 was increased in
both IC and CLI patients compared with controls (P .0001). There wereno differences in levels in patients with IC and CLI. Plasma levels of sTie2
and VEGF were similar in controls and patients with IC, but were increased
in patients with CLI (P .001 vs control or IC). Increased sTie2 and VEGF
were independent of ABI or standard cardiovascular disease risk factors.
Treatment of endothelial cells with VEFG significantly increased sTie2
shedding.
Comment: It is a bit of a stretch to suggest at this time that VEGF and
sTie2 have any utility as biomarkers for the large cohort of patients with CLI.
If, however, these biomarkers could be used as a predictor of amputation risk
in patients with CLI, adjusted for wound size and ABI, that would be useful.
The only real conclusion that can come from this study is that plasma levels
of sTie2 and VEGF are increased in patients with PAD and are different in
those with a clinical diagnosis of CLI vs those with IC. What we really need
in the group of patients with CLI is a predictor of short-term amputation
risk, and the data here are not sufficient for that degree of risk stratification.
Angina Pectoris is a Stronger Indicator of Diffuse Vascular Atheroscle-
rosis than Intermittent Claudication: Framingham Study
Kannel WB, Evans JC, Piper S, et al. J Clin Epidemiol 2008;61:951-7.
Conclusion: Angina pectoris is a stronger predictor of diffuse athero-
sclerotic cardiovascular disease than intermittent claudication (IC).
Summary: IC is an accepted marker of the presence of diffuse athero-
sclerosis and conveys an increased risk for mortality, primarily from cardio-
vascular causes. Angina pectoris, another condition provoked by exertion,
however, is generally regarded only as a hallmark of impending myocardial
infarction. As an example, the Rose angina questionnaire, a tool for epide-
miologic investigation of angina, has been tested chiefly as a predictor of
coronary morbidity and mortality. In this study the authors use population-
based data from the Framingham Study between 1949 and 1990 to assess
relative predictive values of IC or angina pectoris for a cardiovascular disease
event. The data from 1949 to 1990 were used because this was a time when
few widespread therapies were in use for prevention of cardiovascular disease
events.
The prospective cohort of this study consisted of 5209men andwomen
from Framingham, Massachusetts, who were aged 28 to 62 years at the time
of enrollment from 1948 to 1951. For 36 years of follow-up they have
received biennial examinations. The incidence of development of cardiovas-
cular disease in the Framingham participants with angina pectoris or IC was
determined relative to a reference sample free of cardiovascular disease.
There were 95 cardiovascular disease events in the 186 participants with IC,
and 206 in the 413 patients with angina pectoris. Adjusting for sex, age, and
risk factors, the proportion of the IC group developing other cardiovascular
disease was 34%, and the proportion for the angina pectoris group was
43.4%. Compared with the reference sample, the IC group had a 2.73-fold
higher age and sex-adjusted 10-year hazard ratio for cardiovascular disease
(95% confidence interval [CI], 2.21-3.38). For angina pectoris, the cardio-
vascular disease hazard ratio was 3.17 (95% CI, 2.73-3.69). The standard
risk factor adjustments cardiovascular disease hazard ratios were more ele-
vated for patients with angina pectoris than for those patients with IC.
Excess cardiovascular disease was accounted for by risk factors in 34.8% of
those with IC and 9.5% of those with angina pectoris.
Comment: Angina and IC are both hallmarks of diffuse atherosclerotic
vascular disease. The data indicate that both impart a twofold to threefold
increased risk of cardiovascular disease compared with a reference group. It
is interesting that the factors increasing risk for clinical events in other
vascular territories are not a product of the shared risk factors of patients with
IC and those with angina pectoris. Coexistent risk factors only accounted for
about 35% of the cardiovascular risk for IC and 9.5% of the hazard associated
with angina pectoris. The mechanism of this somewhat unexpected obser-
vation is uncertain. It is important to note the Framingham Study has few
African Americans or other minority populations. The data presented,
therefore, cannot be generalized to the entire United States population.
General and Abdominal Adiposity and Risk of Death in Europe
Pischon T, BoeingH,Hoffmann K, et al. N Engl JMed 2008;359:2105-20.
Conclusions: Abdominal adiposity and general adiposity are both
associated with risk of death. Waist circumference and waist-to-hip ratios, in
addition to body mass index (BMI), should be used in assessing risk of death
related to adiposity.
Summary: Calculations of BMI have been used to assess the associa-
tion between adiposity and risk of death. The authors sought to determine
whether the distribution of body fat contributes to the prediction of death
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Prospective Investigation into Cancer and Nutrition (EPIC). The associa-
tion of waist circumference, waist–hip ratio, and BMI was assessed for risk of
death among 359,387 participants in nine European countries. Age was
used as the time variable in a Cox regression analysis and was stratified
according to study center and age at recruitment. Further adjustments were
made for smoking status, alcohol consumption, height, physical activity, and
educational level.
During themean follow-up of 9.7 years, 14,723 participants died.With
respect to BMI, the lowest risk of death was observed at a BMI of 25.3 for
men and 24.3 for women. Adjusting for BMI, waist–hip ratio, and waist
circumference were strongly associated with risk of death. Relative risks
among men and women in the highest quintile of waist circumference were
2.05 (95% confidence interval [CI], 1.82-2.33), and 1.78 (95% CI, 1.56-
2.04), respectively. The waist–hip ratio relative risk for death for men in the
highest quintile was 1.68 (95% CI, 1.53-1.84) and for women was 1.51
(95% CI, 1.37-1.66).
Comment: Adipose tissue, especially adipose tissue associated with
visceral fat deposits, can secrete mediators that are likely important in the
development of chronic diseases. These mediators are thought to potentiate
inflammation that has been associated with respiratory ailments, cancer, and
atherosclerosis. Indeed, a recent report suggests the increased risk of death
associated with a high BMI is driven by cancer and cardiovascular causes
(N Engl J Med 2006;355:779-87). BMI, however, is not the whole story
when it comes to the effect of adipose tissue on life span. The study results
suggest that in patients with low BMI, measurements of waist circumference
or waist-to-hip ratio are more important predictors of the risk of death than
the BMI itself. The study also challenges the use of precise cutoff points to
define the risk of death associated with abdominal obesity. The risk imposed
by the presence of adipose tissue exists essentially as a continuous rather than
as a categoric variable, and it now appears important to assess distribution of
body fat even in persons of normal weight.
APredictiveModel for IdentifyingSurgical Patients atRisk ofMethicillin-
Resistant Staphylococcus Aureus Carriage on Admission
Harbarth S, Sax H, Uckay I, et al. J Am Coll Surg 2008;207:683-9.
Conclusions: Surgical patients recently treated with antibiotics, those
with recent hospitalizations, and those aged 75 years are at increased risk
of being carriers for methicillin resistant Staphylococcus aureus (MRSA) on
admission to the hospital.
Summary:There are guidelines for control of nosocomial transmission
of MRSA (Infect Control Hosp Epidemiol 203;24:362-86). The spread of
MRSA is facilitated by cross-transmission via health care workers’ hands and
broad-spectrum antibiotic treatment selecting for MRSA. MRSA infections
are associated with increased treatment cost and excess morbidity and
mortality. MRSA is now present in the community, and patients without
previous MRSA infection are being increasingly recognized on admission to
the hospital. The authors sought to develop and validate a prediction model
to confine surgical patients with previously unknownMRSAwho are, in fact,
carriers of MRSA on admission to the hospital. The authors used two
prospective studies to derive and validate predictors of previously unknown
MRSA carriage on admission. There were 13,262 patients (derivation
cohort, 3069; validation cohort, 10,193) admitted to the surgery depart-
ment of Geneva University Hospitals in Switzerland. MRSA carriage at the
time of admission increased from 3.2% in 2003 to 5.1% from 2004 to 2006.
Of the patients carrying MRSA, 64% were newly identified carriers. Logis-
tical regression analysis identified three independent factors correlated with
previously unknown MRSA carriage: (1) recent antibiotic treatment (ad-
justed odds ratio [OR], 4.5; P  .001), (2) history of hospitalization
(adjusted OR, 2.7; P .03), and (3) age75 years (adjusted OR, 1.9; P
.048). A score of 0 to 9 points was calculated for these variables. There were
152 patients with a score of 2 points, and previously unknown MRSA
carriage was 5% (n 8); 166 had an intermediate score of 3 to 6 points, and
previously unrecognized MRSA carriage was 11% (n  19); and 87 had a
score 7 points, and previously unrecognized MRSA carriage was 34%
(n  30).
Comment: These data indicate most MRSA carriers are unknown at
the time of hospital admission. The three variables found to be predictive of
unsuspected MRSA infection—previous hospitalization, recent antibiotic
use, and age 75 years—are extremely common in patients with vascular
disease admitted to the hospital. Vascular surgeons should be aware that
many of their patients without previously recognized MRSA infection are
very likely to be carriers of MRSA at the time of their admission to the
hospital.
Identifying Unprovoked Thromboembolism Patients at Low Risk for
Recurrence Who Can Discontinue Anticoagulant Therapy
Rodger MA, Kahn SR, Wells PS, et al. Can Med Assoc J 2008;179:417-26.Conclusion: Oral anticoagulation therapy can be safely discontinued
after 6 months in woman who have zero or one potential predictor of
recurrent venous thromboembolism (VTE).
Summary:Optimal duration of anticoagulation after unprovoked VTE
is controversial. In this study the authors sought to identify clinical predic-
tors to identify patients at low risk of VTE recurrence after discontinuation
of oral anticoagulants.
This was a multicenter prospective cohort study involving 646 patients
with a first unprovoked major VTE. Patients were enrolled during a 4-year
period, and 600 completed a mean 18-month follow-up. Data were col-
lected for 16 potential predictors of recurrent VTE during the time patients
were taking oral anticoagulation therapy (5 to 7 months after initiation).
After discontinuation of oral anticoagulation therapy, patients were moni-
tored for recurrent VTE.
During follow-up, 91 confirmed episodes of recurrent VTE were
identified (annual risk, 9.3%; 95% confidence interval [CI], 7.1%-11.3%).
The annual risk for men was 13.7% (95% CI, 10.8%-17.0%). No combina-
tion of clinical predictors could identify a low-risk subgroup of men. Zero or
one of the following characteristics were present in 52% of women: D-dimer
level 250 mg/L while taking warfarin; body mass index 30 kg/m2;
hyperpigmentation, edema, or redness of either leg; or age 65 years.
Women with zero or one of these predictors had an annual risk of VTE
recurrence of 1.6% (95% CI, 0.3%-4.6%). Women with two or more of these
predictors had an annual risk of VTE recurrence of 14.1% (95% CI, 10.9%-
17.3%).
Comment: This study is consistent with the previously determined
adverse effect of male sex on the recurrence of VTE (Lancet 2006;368:371-
8). There are three major points here. First, identification of risk factors after
5 to 7 months of oral anticoagulation therapy is a strong predictor of
recurrent VTE. Second, D-dimer levels after stopping oral anticoagulation
may not be sufficient to identify patients at low risk of recurrence, whereas
D-dimer levels while taking oral anticoagulationmay be a strong predictor of
recurrent VTE. The point is particularly interesting in that it allows more
efficient care of patients. Stopping anticoagulation and testing D-dimer
levels 1 month later and subsequently restarting anticoagulation therapy if
necessary is impractical and exposes potentially high-risk patients to a period
without anticoagulation. Finally, the authors identified a clinical decision
rule that identifies women at low risk of VTE.
Intermittent Claudication in Diabetes Mellitus Due to Chronic Exer-
tional Compartment Syndrome of the Leg: An Observational Study of
17 Patients
Edmundsson D, Svensson O, Toolanen G. Acta Orthop 2008;79:534-9.
Conclusion: Chronic exertional compartment syndrome (CECS) of
the leg can cause intermittent claudication in patients with diabetes. Fas-
ciotomy provides good results and increased pain-free walking time.
Summary: The authors investigated whether symptoms of claudica-
tion could occur in patients with diabetes as a result of chronic exertional
compartment syndrome (CECS). The report concerns 17 patients (3 men
and 14 women) with a mean age of 39 years (range 18-72 years). All had
diabetes mellitus and 12 had type I diabetes mellitus. All had leg pain during
walking, relieved at rest, and none had clinical signs of peripheral arterial
disease. The mean duration of diabetes was 22 years (range, 1-41 years), and
12 patients had peripheral neuropathy, retinopathy, or nephropathy. Leg
muscles were firm and tender on palpation.
Patients were evaluated with scintigraphy and intramuscular pressure
measurements during exercise. These evaluations resulted in 16 of 17
patients being diagnosed with CECS. Intramuscular compartment pressures
in leg compartments were higher in diabetic patients than in physically active
nondiabetic individuals without CECS (P  .05). The diagnosis of CECS
was made using the following criteria: history of exercised induced pain or
symptoms with reproduction of symptoms and pain during a treadmill
exercise test; or a combination of intramuscular pressures at rest 15 mm
Hg, an intramuscular pressure 30 mm Hg 1 to 2 minutes after the end of
the exercise test, or intramuscular pressure20 mmHg 5 minutes after the
end of the exercise test, all combined with reproduced leg pain. Recom-
mended treatment was fasciotomy of the anterior tibial and peroneal com-
partment using a 5-cm skin incision halfway between the fibular shaft and the
tibial crest in the middle portion of the leg. A 1-cm wide fascial strip was
removed during the procedure. Posterior compartments were treated with
fasciotomy of the superficial soleus and gastrocnemius muscles as well as the
deep posterior compartments.
Fifteen patients were treated with fasciotomy. At surgery the fascia was
observed to be thickened and “whitish,” and to have a “rubber-like”
consistency. After 1 year, 9 patients rated themselves excellent or good in 15
of the 18 treated compartments. Walking times until stopping on the
treadmill test increased after surgery from10 minutes to unlimited time in
8 of the 9 patients who underwent follow-up.
Comment: The authors’ small series suggests CECS may be a cause of
exercise induced leg pain in patients with diabetes. These patients likely
function at different levels than the traditional young athlete with CECS.
Nevertheless, the apparent dramatic increase in pain-free walking in the
